This federal contract IDV, awarded by the Defense Health Agency (DHA), provides a $2,500.00 delivery order to PPD Development LP, a global contract research organization (CRO), for military medical research and development services. The IDV is part of a larger $545 million contract that PPD Development LP holds with the National Institute of Allergy and Infectious Diseases (NIAID) for comprehensive and rapid response capabilities in research programs.
PPD Development LP, a subsidiary of Thermo Fisher Scientific, has also been awarded other significant IDVs with federal agencies, including a $346 million multiple-award contract for NIAID's Early Phase Clinical Trial Units program and a $548 million multiple-award contract with the National Cancer Institute for cancer trials support. These IDVs position PPD Development LP as a critical partner in advancing federal medical research and development initiatives across multiple agencies and therapeutic areas, such as supporting clinical trials, regulatory affairs, and specialized research activities.
Generated 1/15/25, 9:13 AM